About us

Technology based innovative life-science company committed to pursuing
for healthier and cleaner world

History

BioActs’ progress to create innovations
for healthier world

2020s

  • 2022

    BioActs USA Inc
    BALAMP M MRSA Detection Kit KGMP 승인
    - BioActs USA Inc. (sales branch) established
    - BALAMP M MRSA (Methicillin-resistant Staphylococcus aureus) Detection Kit KGMP approved

  • 2021

    체외진단의료기기 제조허가증획득(부산지방식품의약품안전청)
    - Acquired in vitro diagnostic medical device manufacturing license from Ministry of Food and Drug Safety Busan

  • 2020

    의료기기 제조소 인허가 획득(3월, 식약처 한국건설생활환경시험연구원)
    소재부품장비 전문기업 인증(6월, 한국산업기술평가 관리원)
    CytoFlamma CBC Reagent(유세포분석용혈구검사시약) GMP 승인
    지식재산경영기업 선정
    - Acquired medical device manufacturing license in March from Korea Food & Drug Administration and Korea conformity laboratories
    - Certified as a specialized company for material, parts and equipment in June by Korea Evaluation Institute of Industrial Technology
    - CytoFlamma CBC Reagent (whole blood analyzing reagents for flow cytometry) KGMP approved
    - Selected as an intellectual property business corporate

2010s

  • 2019

    Attracted the third round external capital funding.

  • 2018

    Established MOU with Korea Atomic Energy Research Institute (KAERI)

  • 2017

    Selected as INNOBIZ(innovative technology small company)
    Attracted the second round external capital funding.

  • 2016

    Attracted the first round external capital funding.

  • 2015

    Change company name to BioActs

  • 2014

    Selected as a member of K-club of Korea Institute of Science and Technology.

  • 2013

    인천비전기업 선정
    Selected as Incheon Visional Company

  • 2012

    Recognized as a Visionary Company by Incheon Metropolitan city.
    Bioengineering, an affiliated institute of NIH.

  • 2010

    Certified as an Advanced Technology Center (ATC) for biomolecular labeling materials.
    The New Excellent Technology (NET) certification acquired

2000s

  • 2009

    Biological business division (BioActs) established.

  • 2005

    Antibacterial dyes and blue fluorescent OLED material production begin.

  • 2002

    Ningbo Factory and Hangzhou Sales Corporation in China launched.

  • 2001

    Awarded the presidential commendation and 5 million dollars export tower.

1990s

  • 1991

    Affiliated R&D center established; opened an era of innovative growth.

  • 1976

    Corporation established; opened an era of creation and exploration.